Strowitzki T

No ORCID on file · 27 papers in corpus · active 1991-2026

Study types

  • article 9
  • other 5
  • review 3
  • erratum 1
  • preprint 1

Condition tags

  • endometriosis 18
  • chronic_pelvic_pain 6
  • infertility 4
  • dysmenorrhea 3
  • die_deep_infiltrating 2
  • adenomyosis 1
  • dyspareunia 1
other 2026
Pain and therapy ·doi:10.1007/s40122-025-00787-7

INTRODUCTION: Chronic pelvic pain syndrome (CPPS) in women is a debilitating condition with a high prevalence (5-25%), yet its etiology remains unclear. This prospective observational study aimed to identify clinical and medical history cov…

article 2025
Pain and therapy ·doi:10.1007/s40122-025-00760-4

INTRODUCTION: Chronic pelvic pain syndrome (CPPS) is a diagnosis of exclusion in the absence of pathological findings. We aimed to test the hypothesis that cervical motion tenderness (or parametropathy) may serve as a diagnostic tool for CP…

article 2023
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-023-01083-9

BACKGROUND: The pathogenesis of deep infiltrating endometriosis (DIE) is poorly understood. It is considered a benign disease but has histologic features of malignancy, such as local invasion or gene mutations. Moreover, it is not clear whe…

other 2023
Archives of gynecology and obstetrics ·doi:10.1007/s00404-023-07019-3

PURPOSE: This study attempted at identifying the main parameters influencing the outcome of frozen embryo transfers. METHODS: This is a single-center retrospective cohort study of 830 frozen-embryo-transfer cycles performed at a German uni…

preprint 2023
·doi:10.21203/rs.3.rs-3363425/v1

Abstract Purpose Endometriosis and infertility are associated with impaired partnership and sexuality of the patients, but also of their male partners. The aim of this study was to determine the association of different predictors of partne…

erratum 2022
Health and quality of life outcomes ·doi:10.1186/s12955-022-02027-4
2022
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-022-02637-3

The differentiation of endometrial stromal cells, named decidualization, is essential for the proper formation of the materno-fetal interphase. One important feature of decidualization is the increased glucose consumption and its utilizatio…

article 2022
Health and quality of life outcomes ·doi:10.1186/s12955-022-01991-1

BACKGROUND: Endometriosis is often associated with severe dysmenorrhea, pelvic pain and dyspareunia and has a high impact on daily life as well as sexuality. Quality of partnership positively influences the course of various diseases and ab…

other 2021
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-020-00362-9

In order to improve ART outcome, non-invasive embryo assessment is gaining more and more attention. Therefore, the aim of this study is to determine the consecutive implantation potential via the secretome between blastocysts with or withou…

other 2020
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-020-01905-4

PURPOSE: Endometriosis (EM) is a common gynecological disease affecting 10-15% of women of reproductive age. However, molecular mechanisms and pathogenesis are still not completely understood. Furthermore, due to the absence of a reliable c…

2020
Frontiers in endocrinology ·doi:10.3389/fendo.2020.00246

Background: The impact of controlled ovarian stimulation (COS) during medically assisted reproduction (MAR) on human embryogenesis is still unclear. Therefore, we investigated if early embryonic development is affected by the type of gonado…

2019
International journal of molecular sciences ·doi:10.3390/ijms20123066

During the menstrual cycle, the endometrium undergoes cyclic changes of cellular proliferation, differentiation, and death, an essential preparation of the endometrium for its interaction with the implanting embryo. In particular, the diffe…

2019
Geburtshilfe und Frauenheilkunde ·doi:10.1055/a-1017-3389

Introduction Supporting and counselling couples with fertility issues prior to starting ART is a multidisciplinary diagnostic and therapeutic challenge. The first German/Austrian/Swiss interdisciplinary S2k guideline on "Diagnosis and Thera…

2018
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-018-1227-0

PurposeTo study if ovarian response is affected by the type of disease if fertility preservation is required.MethodsA registry of the trinational fertility preservation network FertiPROTEKT including 992 patients aged 18-40 years undergoing…

article 2017
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719117741373

IntroductionTime-lapse technology allows almost continuous noninvasive assessment of embryonic development. It was shown previously that relative kinetics defining cleavage synchronicity are better predictors of blastocyst quality than abso…

2016
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-015-0135-8

BackgroundPharmacokinetic studies with XM17 (Ovaleap®), a recombinant human follicle-stimulating hormone (r-hFSH, follitropin alfa), have demonstrated good safety and tolerability in healthy women whose endogenous FSH levels were down-regul…

article 2015

Thomas Strowitzki,1 Thomas Faustmann,2 Christoph Gerlinger,3,4 Ulrike Schumacher,5,6 Christiane Ahlers,7 Christian Seitz8 1Department of Gynecological Endocrinology and Reproductive Medicine, University of Heidelberg, Heidelberg, Germany; 2…

other 2015
International journal of women's health ·doi:10.2147/IJWH.S77202

BACKGROUND: In four randomized, controlled, European trials, dienogest 2 mg once daily demonstrated significant efficacy for lesion reduction and reduction in pain intensity in endometriosis. We describe a pooled analysis of the safety and …

review 2013
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz ·doi:10.1007/s00103-013-1851-x

BACKGROUND: The incidence of female infertility has not changed since the early 1990s. Based on new data from basic research on infertility, novel options in the diagnostics and treatment of infertility have emerged, besides in vitro fertil…

article 2012
International Journal of Gynecology & Obstetrics ·doi:10.1016/j.ijgo.2012.01.009

OBJECTIVE: To analyze the secondary efficacy and safety outcomes from a recent trial comparing dienogest (DNG) with leuprolide acetate (LA) in women with endometriosis. METHODS: A 24-week, open-label, randomized, multicenter study of DNG ve…

article 2011
Archives of gynecology and obstetrics ·doi:10.1007/s00404-011-1941-7

PURPOSE: To investigate the efficacy and safety of dienogest as a long-term treatment in endometriosis, with follow-up after treatment discontinuation. The study included women with endometriosis, who had previously completed a 12-week, pla…

2010
Reproductive biology and endocrinology : RB&E ·doi:10.1186/1477-7827-8-67

BackgroundReproductive failure, determined as recurrent spontaneous abortions (RSA) or recurrent implantation failure (RIF) in women is not well understood. Several factors, including embryo quality, and cellular and molecular changes in en…

article 2010
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2010.04.002

ObjectiveTo investigate the efficacy and safety of oral dienogest 2mg compared with placebo in the treatment of endometriosis-associated pelvic pain (EAPP).Study designThis was a 12-week, randomized, double-blind, placebo-controlled, multic…

rct 2010
Human Reproduction ·doi:10.1093/humrep/dep469

BACKGROUND: Dienogest is a selective progestin that has been investigated in a clinical trial programme for the treatment of endometriosis. The current non-inferiority trial compared the efficacy and safety of dienogest against leuprolide a…

review 2009
Gynakologisch-geburtshilfliche Rundschau ·doi:10.1159/000197905

Die Implantation ist ein bisher nicht vollständig verstandener Prozess, der zellbiologisch ein Paradoxon darstellt. Zum einen ist der Embryo zu 50% paternal und somit teilweise immunologisch fremd, und zum anderen sind das Endometrium und d…